Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial
Titel:
Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial
Auteur:
Gordon, Kenneth B Foley, Peter Krueger, James G Pinter, Andreas Reich, Kristian Vender, Ronald Vanvoorden, Veerle Madden, Cynthia White, Katy Cioffi, Christopher Blauvelt, Andrew